Literature DB >> 23945646

Microparticle-associated tissue factor is recycled by endothelial cells resulting in enhanced surface tissue factor activity.

M E W Collier1, P-M Mah, Y Xiao, A Maraveyas, C Ettelaie.   

Abstract

In this study the uptake of tissue factor (TF)-positive microparticles by endothelial cells and the recycling of the TF component were examined. Human dermal blood endothelial cells (HDBEC) were incubated with microparticles derived from cancer cell lines for up to 6 hours. Measurement of HDBEC cell surface TF antigen revealed two distinct peaks at 30 and 180-240 minutes post-incubation with TF-positive, but not TF-deficient microparticles. However, only the second peak was concurrent with high TF activity as determined by a chromogenic thrombin-generation assay. Annexin V-labelling of HDBEC showed phosphatidylserine exposure following 90 minutes incubation with microparticles, which explains the high TF activity associated with the second antigen peak. Analysis of TF mRNA levels revealed no de novo expression of TF mRNA in response to microparticles, and pre-incubation of cells with cycloheximide did not prevent the appearance of TF. However, blocking endocytosis with a dynamin inhibitor prolonged the disappearance and prevented the reappearance of TF antigen on the cell surface. Incubation of HDBEC with microparticles containing TF-GFP revealed the early co-localisation of TF with Rab4 and Rab5, followed by co-localisation with the late endosomal/trans-Golgi network marker Rab9, and the recycling endosome marker Rab11. siRNA-mediated suppression of Rab11 reduced the reappearance of TF on the cell surface. These data suggest a mechanism by which TF-containing microparticles are internalised by endothelial cells and the TF moiety recycled to the cell surface. Together with the exposure of phosphatidylserine, this is capable of inducing a substantial increase in the procoagulant potential of the surface of endothelial cells.

Entities:  

Keywords:  Tissue factor; endosome; endothelial cells; microparticles; procoagulant activity; recycling

Mesh:

Substances:

Year:  2013        PMID: 23945646     DOI: 10.1160/TH13-01-0055

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  Cancer cell-derived tissue factor-positive extracellular vesicles: biomarkers of thrombosis and survival.

Authors:  Yohei Hisada; Nigel Mackman
Journal:  Curr Opin Hematol       Date:  2019-09       Impact factor: 3.284

2.  Extracellular vesicles: another compartment for the second messenger, cyclic adenosine monophosphate.

Authors:  Sarah L Sayner; Chung-Sik Choi; Marcy E Maulucci; K C Ramila; Chun Zhou; April K Scruggs; Thomas Yarbrough; Leslie A Blair; Judy A King; Roland Seifert; Volkhard Kaever; Natalie N Bauer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-13       Impact factor: 6.011

3.  Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages.

Authors:  Mariluz Araínga; Dongwei Guo; Jayme Wiederin; Pawel Ciborowski; JoEllyn McMillan; Howard E Gendelman
Journal:  Retrovirology       Date:  2015-01-22       Impact factor: 4.602

Review 4.  The central role of extracellular vesicles in the mechanisms of thrombosis in paroxysmal nocturnal haemoglobinuria: a review.

Authors:  Bérangère Devalet; François Mullier; Bernard Chatelain; Jean-Michel Dogné; Christian Chatelain
Journal:  J Extracell Vesicles       Date:  2014-03-24

5.  Extracellular vesicles, tissue factor, cancer and thrombosis - discussion themes of the ISEV 2014 Educational Day.

Authors:  Chris Gardiner; Paul Harrison; Mattias Belting; Anita Böing; Elena Campello; Bob S Carter; Mary E Collier; Frank Coumans; Camille Ettelaie; Nick van Es; Fred H Hochberg; Nigel Mackman; Robert C Rennert; Johannes Thaler; Janusz Rak; Rienk Nieuwland
Journal:  J Extracell Vesicles       Date:  2015-03-13

Review 6.  Extracellular vesicles: how they interact with endothelium, potentially contributing to metastatic cancer cell implants.

Authors:  Murray M Bern
Journal:  Clin Transl Med       Date:  2017-09-21

7.  Procoagulant tumor microvesicles attach to endothelial cells on biochips under microfluidic flow.

Authors:  Abdulrahman Algarni; John Greenman; Leigh A Madden
Journal:  Biomicrofluidics       Date:  2019-12-06       Impact factor: 2.800

Review 8.  The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.

Authors:  Nicola Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

9.  Characterization of physical properties of tissue factor-containing microvesicles and a comparison of ultracentrifuge-based recovery procedures.

Authors:  Camille Ettelaie; Mary E W Collier; Anthony Maraveyas; Rammile Ettelaie
Journal:  J Extracell Vesicles       Date:  2014-08-13

10.  Analysis of the potential of cancer cell lines to release tissue factor-containing microvesicles: correlation with tissue factor and PAR2 expression.

Authors:  Camille Ettelaie; Mary Ew Collier; Sophie Featherby; Naima E Benelhaj; John Greenman; Anthony Maraveyas
Journal:  Thromb J       Date:  2016-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.